The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study
Open accessAbstract
OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes and whether reversion has any effect on type 1 diabetes risk. RESEARCH DESIGN AND METHODS: Children were up to 10 years of age and screened more than once for insulin autoantibody, GAD antibody, and insulinoma antigen-2 antibodies. Persistent autoantibody was defined as an autoantibody present on two or more consecutive visits and confirmed in two reference laboratories. Reversion was defined as two or more consecutive negative visits after persistence. Time-dependent Cox regression was used to examine how reversion modified the risk of development of multiple autoantibodies and type 1 diabetes. RESULTS: Reversion was relatively frequent for autoantibodies to GAD65 (19%) and insulin (29%), but was largely restricted to children who had single autoantibodies (24%) and rare in children who had developed multiple autoantibodies (<1%). Most (85%) reversion of single autoantibodies occurred within 2 years of seroconversion. Reversion was associated with HLA genotype, age, and decreasing titer. Children who reverted from single autoantibodies to autoantibody negative had, from birth, a risk for type 1 diabetes of 0.14 per 100 person-years; children who never developed autoantibodies, 0.06 per 100 person-years; and, children who remained single-autoantibody positive, 1.8 per 100 person-years. CONCLUSIONS: Type 1 diabetes risk remained high in children who had developed multiple β-cell autoantibodies even when individual autoantibodies reverted. We suggest that monitoring children with single autoantibodies for at least 1 year after seroconversion is beneficial for stratification of type 1 diabetes risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In several cohort studies, up to 50% of children with only a single autoantibody revert to being islet autoantibody negative during follow-up (79,80).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [80]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationZiegler, A., Hummel, M., Schenker, M., & Bonifacio, E. E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 640
Self-citationBingley, P. J., Bonifacio, E. E., Williams, A. J. K., Genovese, S., Bottazzo, G. F., & Gale, E. A. (1997) · Diabetes · doi:10.2337/diab.46.11.1701 · Cited by 460
Self-citationthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444
Self-citationThe Environmental Determinants of Diabetes in the Young (TEDDY) study: study design
The TEDDY Study Group (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00269.x · Cited by 369
Self-citationBarker, J. M., Barriga, K. J., Yu, L., Miao, D., Erlich, H. A., Norris, J. M., Eisenbarth, G. S., & Rewers, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031887 · Cited by 352
Self-citationQuantification of islet-cell antibodies and prediction of insulin-dependent diabetes
Bonifacio, E. E., Shattock, M., Dean, B. M., Bottazzo, G. F., Bingley, P. J., Gale, E., & Dunger, D. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)90013-u · Cited by 344
Self-citationThe Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 311
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–103 of 103
Addala, A., Cabrera, S. M., Cuthbertson, D., Libman, I. M., Tosur, M., Siller, A. F., DiMeglio, L. A., Herold, K. C., REDONDO, M. J., & Ismail, H. M. (2026) · Diabetes Care · doi:10.2337/dc26-0387
Yaneva, N. Y., Popov, T. T., Petrova, M., Yordanova, A., Arshinkova, M., Kyurkchiev, D. S., & Kurteva, E. K. (2026) · Life · doi:10.3390/life16091500
Zum Beitrag: Positionspapier der DDG zum Typ-1-Diabetes-Screening
Bonifacio, E. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2907-3214
Self-citation
Metadata
- Authors
- Vehik, K., Lynch, K. F., Schatz, D. A., Akolkar, B., Hagopian, W., Rewers, M., She, J.-X., Simell, O., Toppari, J., Ziegler, A.-G., Lernmark, Å., Bonifacio, E., Krischer, J. P., & the TEDDY Study Group
- Affiliations
- University of South Florida (US)
- University of Florida (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Pacific Northwest Research Institute (US)
- University of Colorado Health (US)
- Augusta University (US)
- Turku University Hospital (FI)
- TUM Klinikum (DE)
- Lund University (SE)
- German Center for Diabetes Research (DE)
- Corresponding author
- Vehik, Kendra
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-06-16
- Volume
- 39
- Issue
- 9
- Pages
- 1535-1542
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC5001144
- OpenAlex
- W2438883383
- Cited by
- 103
- References
- 27
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 17 · 2023: 10 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 5
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-63829, U01-DK-63861, U01-DK-63821, U01-DK-63865, U01-DK-63863, U01-DK-63836, U01-DK-63790, Contract No. HHSN267200700014C)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, islet autoimmunity, insulin autoantibodies, GAD65 antibodies, preclinical type 1 diabetes, type 1 diabetes risk, seroconversion, HLA genotypes, vulnerable children, TEDDY study
- MeSH terms
- Seroconversion, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Genotype, Glutamate Decarboxylase, Humans, Insulin, Insulin Antibodies, Male, Prospective Studies, Risk Factors, Autoimmunity, Risk Assessment, Insulin-Secreting Cells, Receptor-Like Protein Tyrosine Phosphatases, Class 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
